HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 216 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $231,000 | -9.8% | 14,874 | -0.1% | 0.00% | 0.0% |
| Q2 2019 | $256,000 | +9.9% | 14,892 | +2.8% | 0.00% | 0.0% |
| Q1 2019 | $233,000 | +16.5% | 14,493 | +6.6% | 0.00% | 0.0% |
| Q4 2018 | $200,000 | -45.2% | 13,591 | -32.4% | 0.00% | -50.0% |
| Q3 2018 | $365,000 | +4.9% | 20,096 | -2.5% | 0.00% | 0.0% |
| Q2 2018 | $348,000 | +41.5% | 20,602 | +63.7% | 0.00% | +100.0% |
| Q1 2018 | $246,000 | -5.7% | 12,583 | -2.3% | 0.00% | -50.0% |
| Q4 2017 | $261,000 | +6.5% | 12,882 | -8.7% | 0.00% | +100.0% |
| Q3 2017 | $245,000 | +30.3% | 14,106 | -3.5% | 0.00% | 0.0% |
| Q2 2017 | $188,000 | – | 14,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |